Ginwa Enterprise (Group) Inc. (SHA:600080)

Market Cap	2.93B +7.2%
Revenue (ttm)	550.44M -5.3%
Net Income	78.32M
EPS	0.23
Shares Out	352.71M
PE Ratio	36.86
Forward PE	n/a
Dividend	0.03 (0.35%)
Ex-Dividend Date	n/a

Volume	6,915,397
Average Volume	13,539,621
Open	8.56
Previous Close	8.57
Day's Range	8.29 - 8.59
52-Week Range	6.23 - 9.35
Beta	0.39
RSI	51.42
Earnings Date	Apr 25, 2026

About Ginwa Enterprise (Group)

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 588
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600080